---
id: 220
title: Lung Abscess
category: clinical_syndromes
subcategory: respiratory
tags: [lung-abscess, aspiration, anaerobes, clindamycin, cavitation]
difficulty: medium
---

## Question

How is lung abscess managed? Use **"Prolonged Antibiotics (Clindamycin × 4-6 Weeks), Drainage if Failed Medical Therapy"** framework.

## Answer

### **Definition:**

- **Necrotic cavity** (>2 cm) in lung parenchyma with **air-fluid level**

### **Classification:**

**Primary (Aspiration):**
- **Most common** (70-80%)
- **Risk factors:** Alcoholism, seizures, dysphagia, poor dentition, altered consciousness

**Secondary:**
- **Post-obstructive:** Endobronchial lesion (tumor, foreign body)
- **Septic emboli:** Endocarditis, IVDU
- **Immunocompromised:** Opportunistic organisms (*Nocardia*, *Aspergillus*, *Mycobacteria*)

### **Microbiology:**

**Aspiration (Primary):**
- **Anaerobes** (60-80%): *Fusobacterium*, *Prevotella*, *Peptostreptococcus*, *Bacteroides*
- **Mixed aerobic/anaerobic** (common)
- **Foul-smelling sputum** (pathognomonic for anaerobes)

**Secondary:**
- ***Staphylococcus aureus*** (post-influenza, IVDU, endocarditis)
- ***Klebsiella pneumoniae*** (alcoholics, diabetes, "currant jelly" sputum)
- ***Pseudomonas aeruginosa*** (bronchiectasis, cystic fibrosis)
- ***Nocardia asteroides*** (immunocompromised)
- **Fungi:** *Aspergillus*, mucormycosis (neutropenia)
- ***Mycobacterium tuberculosis***

### **Clinical Presentation:**

**Subacute/Chronic:**
- **Cough with purulent sputum** (often foul-smelling)
- **Fever, night sweats, weight loss** (mimics TB)
- **Hemoptysis** (25%)
- **Pleuritic chest pain**

**Physical Exam:**
- **Dullness to percussion, decreased breath sounds** over affected area

### **Diagnosis:**

**Imaging:**

**Chest X-Ray:**
- **Cavitation with air-fluid level** (thick-walled cavity, irregular borders)
- **Most common locations:** Posterior segments upper lobes, superior segments lower lobes (gravity-dependent if aspiration)

**CT Chest:**
- **Better delineates cavity, surrounding consolidation**
- **Distinguishes abscess from empyema** (empyema = lenticular, follows pleural contour; abscess = spherical, crosses fissures)

**Microbiologic Diagnosis:**

**Sputum Culture:**
- **Often contaminated** by oral flora (limited utility)

**Blood Cultures:**
- **Rarely positive** (<10%)

**Bronchoscopy with BAL:**
- **If no improvement** with empiric therapy (r/o obstruction, malignancy, atypical organisms)
- **Protected specimen brush, BAL culture**

**CT-Guided Aspiration:**
- **If refractory, immunocompromised** (r/o *Nocardia*, fungi, *Mycobacteria*)

### **Treatment:**

**Antibiotics (Prolonged):**

**Empiric (Aspiration, Community-Acquired):**
- **Clindamycin 600-900mg IV q8h** (first-line, excellent anaerobic coverage)
- OR **ampicillin-sulbactam 3g IV q6h**
- OR **pip-tazo 3.375-4.5g IV q6-8h**

**Alternative:**
- **Metronidazole 500mg IV q8h + ceftriaxone 2g IV daily** (if PCN allergy)
- **Meropenem 1g IV q8h** (if severe)

**Oral Step-Down (After Clinical Improvement):**
- **Clindamycin 300-450mg PO TID**
- **Amoxicillin-clavulanate 875mg PO BID**

**Pathogen-Directed (If Culture Available):**

***S. aureus*:**
- **MSSA:** Nafcillin/cefazolin
- **MRSA:** Vancomycin, linezolid

***K. pneumoniae*:**
- **Ceftriaxone** (if susceptible) OR **carbapenem** (if ESBL)

***Pseudomonas*:**
- **Pip-tazo, cefepime, meropenem, ciprofloxacin**

***Nocardia*:**
- **TMP-SMX high-dose** + consider combination (amikacin, imipenem) × ≥6 months

**Duration:**
- **4-6 weeks** (minimum)
- **Until cavity resolved or small residual scar** (may take months)
- **Longer if:** Large abscess (>6 cm), immunocompromised, slow response

### **Drainage (Selective):**

**Indications for Drainage:**
- **Failed medical therapy** (persistent fever, enlarging cavity after 7-10 days)
- **Large abscess** (>6 cm)
- **Thick-walled cavity** (unlikely to resolve with antibiotics alone)
- **Suspected obstruction** (tumor, foreign body)

**Methods:**
- **CT-guided percutaneous drainage** (catheter placement)
- **Bronchoscopy** (drain central cavities)
- **Surgical resection** (lobectomy) - if refractory, concern for malignancy, massive hemoptysis

### **Monitoring:**

**Clinical Improvement:**
- **Afebrile within 7-10 days** (if no improvement → reassess)
- **Decreased WBC, CRP**

**Imaging:**
- **Repeat CXR** at 4-6 weeks (cavity may take months to resolve)
- **CT if no improvement** (r/o obstruction, empyema, malignancy)

### **Complications:**

- **Empyema** (rupture into pleural space)
- **Massive hemoptysis** (erosion into bronchial artery)
- **Bronchopleural fistula**
- **Sepsis**

### **Prognosis:**

**Overall Cure Rate:** 80-90% (with prolonged antibiotics)

**Predictors of Poor Outcome:**
- **Large abscess** (>6 cm)
- **Immunocompromised**
- **Delayed treatment**
- ***S. aureus*, *K. pneumoniae*, *Pseudomonas***

## Key Points

### **Aspiration = Anaerobes:**
- **Foul-smelling sputum** (pathognomonic)
- **Poor dentition, alcoholism, aspiration risk**

### **Clindamycin = First-Line:**
- **Excellent anaerobic coverage**
- **600-900mg IV q8h** (initially) → 300-450mg PO TID (step-down)

### **Prolonged Duration:**
- **4-6 weeks** (minimum)
- **Until cavity resolved** or small residual scar

### **Drainage if Failed Medical Therapy:**
- **Persistent fever after 7-10 days**
- **Large abscess** (>6 cm)
- **Suspected obstruction**

### **CT > CXR:**
- **Distinguishes abscess from empyema**
- **Air-fluid level** in spherical cavity (crosses fissures)

### **Clinical Pearls:**
- **Aspiration lung abscess:** Clindamycin 600-900mg IV q8h → PO × **4-6 weeks**
- **Foul-smelling sputum** = anaerobes
- **Posterior upper lobes, superior lower lobes** (gravity-dependent aspiration)
- **Drainage** if failed medical therapy (7-10 days), large abscess (>6 cm)
- **Cavity may take months to resolve** (repeat CXR at 4-6 weeks)
- **If immunocompromised:** Consider *Nocardia*, *Aspergillus*, *Mycobacteria*

## Sources

- [IDSA: Aspiration Pneumonia Guidelines 2024]
- [Chest: Lung Abscess Management 2024]

## Media

N/A
